LOCAL PROVIDER DIRECTORY
Find a dentist
Search by name or specialty, then choose a city and region or enter a ZIP / postal code.
Choose a location to keep your results local.
Local Health Alerts
Do I Need to Stop Using Recalled MG217 Eczema Cream?
FDA says one lot of MG217 eczema cream was recalled after Staphylococcus aureus contamination was found. Here is how to check your tube, why eczema patients may face higher risk, and what symptoms should prompt medical care.
Who Qualifies for Medicare’s $50 GLP-1 Bridge Starting July 1, 2026?
CMS’s new Medicare GLP-1 Bridge starts July 1, 2026, but it is not broad new obesity-drug coverage for everyone. Here is who may qualify, which drugs and uses are included, and what the $50 monthly price does not count toward under Part D.
Dexcom G7 stolen-sensor recall: how to check your lot number and what to do now
FDA posted a Dexcom safety notice on May 29 after the company said two stolen G7 sensor lots entered the U.S. market. Here is how to check your lot number, when backup fingerstick checks matter, and which symptoms need prompt care.
Should Americans worry about Andes virus after the cruise ship outbreak?
The Andes virus outbreak linked to the M/V Hondius is serious for exposed travelers, but most Americans do not need testing or major changes unless they had a specific exposure or hear from public health officials.
New U.S. Cholesterol Guidance Highlights Earlier Risk Review
A March 2026 multisociety guideline says some adults may need earlier cholesterol risk review, one-time Lp(a) testing, and more personalized prevention decisions.
Cruise Ship Andes Virus Outbreak: How Worried Should People in the U.S. Be?
CDC says the risk to the general U.S. public is low, but cruise passengers, traced contacts, and anyone with a known close exposure should watch for symptoms and act quickly if they get sick.
Can You Self-Collect an HPV Test for Screening Now? What Changed in 2026
ACOG now includes patient-collected high-risk HPV screening in cervical cancer guidance for average-risk adults ages 30 to 65, but the change is narrower than many headlines suggest. Federal preventive-coverage changes tied to the HRSA update generally begin with plan years starting in 2027,…
Why the FDA’s trial-results push matters for patients and readers
The FDA is pressing more than 2,200 sponsors and researchers to post required clinical trial results to ClinicalTrials.gov. For patients and readers, the issue is simple: missing results can distort what we think works, what does not, and how safe a medical product…
Long COVID fatigue study raises interest in fluvoxamine, not a new standard
A new randomized trial found a signal that fluvoxamine may ease long COVID fatigue, but the evidence is still early and does not change routine care yet. CDC guidance says there are no approved tests or treatments for Long COVID, and treatment remains…
Postpartum diabetes testing after gestational diabetes: what the trial found
A randomized trial suggests that moving the postpartum glucose test to the hospital stay may help more people with gestational diabetes complete screening. The result points to a practical problem: after delivery, follow-up testing can fail because of logistics, not just motivation.
Can fluvoxamine help long COVID fatigue? Early trial results show a possible signal, but it is not practice-changing
A new randomized study suggests fluvoxamine may ease long COVID fatigue for some people, but the finding is narrow, early, and not enough to change routine care. CDC guidance still says long COVID is diagnosed clinically, there is no approved test, and treatment…
FDA’s March 2026 rare-disease approvals: what families should know
Three FDA decisions in March 2026 gave families in the rare-disease world something unusual: approved options for conditions that previously had few or none. Here’s what changed, what the evidence looked like, and what still needs to be watched closely.
